Julia is the associate news editor for Health, where she edits and publishes news articles on trending health and wellness topics. Her work has been featured in The Heights, an independent student ...

These data, representing one of the largest TNBC MRD datasets analyzed to date, 1 were presented by Dr. Marija Balic, MD, PhD, scientific director of the NSABP Translational Research Program, at the ...

MADISON, Wis.--(BUSINESS WIRE)-- Exact Sciences Corp. (EXAS), a leading provider of cancer screening and diagnostic tests, today announced the first clinical study results from its Oncodetect ® ...

Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced the first clinical study results from its Oncodetect® molecular residual disease (MRD) ...

MADISON, Wis., December 11, 2025--(BUSINESS WIRE)--Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced the first clinical study results ...

Abbott, a Chicago-based pharmaceutical company, is acquiring Madison-based biotechnology company Exact Sciences, which will become a subsidiary of Abbott, in a $21 billion deal, the companies ...

Madison leaders and economists are still working to predict all of the major changes that could take place with the sale of local cancer diagnostics company Exact Sciences to Illinois-based Abbott ...